⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HRMY News
Harmony Biosciences Holdings, Inc. Common Stock
Form 8-K
sec.gov
HRMY
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
businesswire.com
HRMY
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
businesswire.com
HRMY
Harmony Biosciences to Participate in Upcoming Investor Conferences
businesswire.com
HRMY
Form 8-K
sec.gov
HRMY
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
businesswire.com
HRMY
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
businesswire.com
HRMY
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
businesswire.com
HRMY
Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX ® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
businesswire.com
HRMY
Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX ® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
businesswire.com
HRMY